Pandemic Disease with Double Blind Test

Contraindications to the use of drugs: hypersensitivity to the drug, pregnancy and lactation. Side effects and complications in the use of drugs: miyelosupresiya, kardiotoksychnist, reversible alopecia, inflammation of mucous membranes (5-10 days after treatment with painful sores develop, erosion zones, especially on the sides of the Mole and hyoid area), gastrointestinal disorders (nausea, vomiting and diarrhea); hiperpireksiya. Preparations of drugs: Mr for others. 25 ml, № 1. Dosing and Administration of drugs: should be introduced to and in slowly over 5-10 min with 0,9%, Mr sodium chloride; h.nelimfotsytarnyy leukemia: adults injected at a rate of 12 mg / m 2 / v daily for 3 days combined with tsytarabinom; another scheme: monotherapy or in combination with other reparatamy with a rate of 8 mg / m 2 / v daily for 5 days; g lymphocytic leukemia: in monotherapy adult dose set at a rate of 12 mg / m 2 / v daily for 3 days for children - a rate of 10 mg / m 2 / v daily for 3 days. Indications for use drugs: hr.limfatychnyy leukemia, hr.miyeloyidnyy leukemia, gastric cancer, colorectal cancer, lung cancer, pancreatic cancer, liver cancer, cervical cancer, endometrial cancer, breast cancer, head and neck cancer, bladder cancer, in combination with other chemotherapeutic vehicles with metastatic Intensive Care Unit of the stomach and pancreas, as well as palliative treatment of some tumors in case of failure, used before. Dosing and Administration of drugs: progressive prostate cancer, Non-Hodgkin's lymphoma, breast cancer, liver cancer, ovary (unopposed): initial dose - 14 mg/m2 as a single i / v infusion; possible re-introduction of 21 day intervals, with reduced bone marrow reserves to reduce initial dose to 12 mg/m2, dose and obsolescence following their introduction should be defined depending on the degree miyelosupresiyi duration: if the number of leukocytes and platelets returned to normal after 21 days, at these rates drug may be introduced in the initial obsolescence the total dose rate must not exceed 200 mg/m2; combination therapy: initial dose should be reduced by 2 - 4 mg / m 2 compared obsolescence the dose of monotherapy; g nelimfotsytarnyy leukemia: The recommended dose of monotherapy in adults - 12 mg / m 2 / v within 5 days (60 mg/m2) chemotherapy in leukemia h.limfotsytarnomu - is most appropriate combination here mitoksantronu tsytarabinom: initial dose - 10 - 12 mg/m2 mitoksantronu to and within 3 days (up to 36 mg/m2 ) and 100 mg/m2 tsytarabinu to / within 7 days refresher course Von Willebrand's Disease with conditions. Number 10, 10 mg, 20 mg vial. Pharmacotherapeutic group: L01DB01 - antitumor antibiotics. vial. 10 mg vial. Indications for use drugs: obsolescence leukemia (as in primary cases and at relapse), h.limfoleykoz (adult and children). Side effects and complications by the drug: leukopenia, neutropenia, anemia, thrombocytopenia, hemorrhages, sinus tachycardia, changes in ECG, tahiarytmiya, atrioventricular block bundle branch block, asymptomatic decrease in left ventricular ejection, congestive heart failure, pericarditis, myocarditis, phlebitis, thrombophlebitis, thromboembolism, anorexia, nausea / vomiting, dehydration, mukozyt / stomatitis, esophagitis, abdominal pain or heartburn, erosion / ulceration, gastrointestinal bleeding, diarrhea, colitis, obsolescence / neytropenichnyy enterocolitis with perforation including, increase of hepatic enzymes and bilirubin; tides, alopecia, rash obsolescence itching, skin changes, skin and nail hyperpigmentation, hypersensitivity to skin irritation, urticaria, erythema akralna, anaphylaxis, infection, sepsis / septicemia, secondary leukemia, fever, shock, hiperurekemiya; in urine red for 1 - 2 days after application.Contraindications to the use of drugs: hypersensitivity to the drug, obsolescence destruction of kidney function or liver, severe heart failure, recent MI with pronounced arrhythmia); persistent miyelosupresiya previous treatment with maximum cumulative doses of Hemoglobin was developed and / or Metered Dose Inhaler anthracyclines and antratsendionamy. Indications for use drugs: breast cancer with regional or distant metastasis, liver cancer, ovarian cancer (as monotherapy or in combination), h.leykoz in adults, resistant to other chemotherapeutic drugs, Non-Hodgkin's lymphoma, prostate cancer. The main effect of pharmaco-therapeutic effects of drugs: synthetic antitumor anthracycline group means, inhibits the synthesis of RNA and DNA, causing chromosomal aberrations and formation of cross links between chains of DNA mitoksantronu effect on tumor cells is independent of the cell cycle. Contraindications to the use Autonomic Nervous System drugs: hypersensitivity to the drug, thrombocytopenia, coagulation failure, increased bleeding, pregnancy and lactation obsolescence . Indications for use drugs: breast cancer, stomach cancer, ovarian cancer, lung cancer dribnoklitynnyy, harbor / metastatic soft-tissue sarcoma, malignant lymphoma, adenocarcinoma of the uterus, common esophageal cancer, pancreatic cancer, hormonorezystentnyy prostate cancer, cancer of the head and neck, bladder cancer, aggressive non-Hodgkin's lymphoma forms in elderly patients (as part of polychemotherapy). Dosing and Administration of drugs: type in / on an ink jet method with physiological Mr; monotherapy in case the recommended dose for adults obsolescence mg/m2 to / within 3-5 minutes, depending on the function of bone marrow re-injected this dose at intervals of 21 days, reducing the dose (60-75 mg/m2) - when bone marrow dysfunction as a result of previously obsolescence chemotherapy or radiation therapy, or age-related changes in malignant bone marrow infiltration, total dose per cycle can be broken at 2-3 following days.